UQCC2 Gene Mitochondrial Complex III Deficiency Nuclear Type 7 Genetic Test
About the Test
The UQCC2 Gene Mitochondrial Complex III Deficiency Nuclear Type 7 Genetic Test is a diagnostic test offered by DNA Labs UAE. This test is designed to identify mutations in the UQCC2 gene, which is responsible for mitochondrial complex III deficiency, nuclear type 7. This rare genetic disorder affects the function of mitochondria, the energy-producing structures within cells.
Test Components
- Test Name: UQCC2 Gene Mitochondrial Complex III Deficiency Nuclear Type 7 Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
- Pre Test Information: Clinical History of Patient who is going for UQCC2 Gene Mitochondrial Complex III Deficiency, Nuclear Type 7 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with UQCC2 Gene Mitochondrial Complex III Deficiency, Nuclear Type 7
Test Details
UQCC2 gene mitochondrial complex III deficiency, nuclear type 7 is a rare genetic disorder that affects the function of the mitochondria, which are the energy-producing structures within cells. This condition is caused by mutations in the UQCC2 gene, which provides instructions for making a protein involved in the assembly and stability of complex III in the mitochondrial respiratory chain. Mitochondrial complex III is a crucial component of the electron transport chain, which is responsible for generating energy in the form of ATP. Mutations in the UQCC2 gene can disrupt the normal function of complex III, leading to a deficiency in energy production.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of UQCC2 gene mitochondrial complex III deficiency, nuclear type 7, NGS genetic testing can be used to identify mutations in the UQCC2 gene and confirm the diagnosis of the condition. NGS genetic testing involves obtaining a DNA sample, typically through a blood sample, and analyzing the DNA for specific genetic variations. This type of testing can provide comprehensive and accurate results, allowing for a more precise diagnosis and better understanding of the genetic basis of the condition.
The results of NGS genetic testing can help healthcare professionals develop appropriate treatment plans and provide genetic counseling to affected individuals and their families. Additionally, this testing can contribute to research efforts aimed at understanding the underlying mechanisms of UQCC2 gene mitochondrial complex III deficiency, nuclear type 7 and developing potential therapies.
| Test Name | UQCC2 Gene Mitochondrial complex III deficiency nuclear type 7 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for UQCC2 Gene Mitochondrial complex III deficiency, nuclear type 7 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with UQCC2 Gene Mitochondrial complex III deficiency, nuclear type 7 |
| Test Details |
UQCC2 gene mitochondrial complex III deficiency, nuclear type 7 is a rare genetic disorder that affects the function of the mitochondria, which are the energy-producing structures within cells. This condition is caused by mutations in the UQCC2 gene, which provides instructions for making a protein involved in the assembly and stability of complex III in the mitochondrial respiratory chain. Mitochondrial complex III is a crucial component of the electron transport chain, which is responsible for generating energy in the form of ATP. Mutations in the UQCC2 gene can disrupt the normal function of complex III, leading to a deficiency in energy production. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of UQCC2 gene mitochondrial complex III deficiency, nuclear type 7, NGS genetic testing can be used to identify mutations in the UQCC2 gene and confirm the diagnosis of the condition. NGS genetic testing involves obtaining a DNA sample, typically through a blood sample, and analyzing the DNA for specific genetic variations. This type of testing can provide comprehensive and accurate results, allowing for a more precise diagnosis and better understanding of the genetic basis of the condition. The results of NGS genetic testing can help healthcare professionals develop appropriate treatment plans and provide genetic counseling to affected individuals and their families. Additionally, this testing can contribute to research efforts aimed at understanding the underlying mechanisms of UQCC2 gene mitochondrial complex III deficiency, nuclear type 7 and developing potential therapies. |
